Don’t Count On Woolly Mammoths To Save The Planet
By Frederick Hewett,
WBUR
| 09. 27. 2021
“What we need to fight climate change is woolly mammoths” — said no climate scientist, ever.
But that’s not deterring a hotshot bioscience start-up from peddling its genetic tinkering as a way to reduce greenhouse gas emissions. On its slick website, newly-formed Colossal Laboratories prominently states that its top core goal is “to decelerate melting of the arctic permafrost.” Melting permafrost releases immense quantities of methane into the atmosphere, which contributes to global warming.
To achieve their stated goal, the founders plan to genetically engineer a hybrid of the Asian elephant and the extinct woolly mammoth, which last lived about 4,000 years ago. If you don’t immediately see how that relates to the climate crisis, hang on.
The pitch goes like this. First, the gene-splicing wizards will synthesize some carefully chosen woolly mammoth genes — the animal's complete genetic sequence has been known since 2015 — and implant them in an egg cell from an Asian elephant. Egg harvesting is hugely complex with elephants, and the Asian elephant is endangered. (Colossal’s fallback strategy is to make an embryo from stem...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...